• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form D filed by Hempacco Co. Inc.

    4/2/24 4:30:36 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email
    SEC FORM D

    The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
    The reader should not assume that the information is accurate and complete.

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM D

    Notice of Exempt Offering of Securities

    OMB APPROVAL
    OMB Number: 3235-0076
    Estimated average burden
    hours per response: 4.00

    1. Issuer's Identity

    CIK (Filer ID Number) Previous Names
    X None
    Entity Type
    0001892480
    X Corporation
       Limited Partnership
       Limited Liability Company
       General Partnership
       Business Trust
       Other (Specify)

    Name of Issuer
    Hempacco Co., Inc.
    Jurisdiction of Incorporation/Organization
    NEVADA
    Year of Incorporation/Organization
       Over Five Years Ago
    X Within Last Five Years (Specify Year) 2019
       Yet to Be Formed

    2. Principal Place of Business and Contact Information

    Name of Issuer
    Hempacco Co., Inc.
    Street Address 1 Street Address 2
    9925 Airway Road
    City State/Province/Country ZIP/PostalCode Phone Number of Issuer
    San Diego CALIFORNIA 92154 619-779-0715

    3. Related Persons

    Last Name First Name Middle Name
    Piancone Sandro
    Street Address 1 Street Address 2
    9925 Airway Road
    City State/Province/Country ZIP/PostalCode
    San Diego CALIFORNIA 92154
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Pearson Neville
    Street Address 1 Street Address 2
    9925 Airway Road
    City State/Province/Country ZIP/PostalCode
    San Diego CALIFORNIA 92154
    Relationship: X Executive Officer    Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Olson Jorge
    Street Address 1 Street Address 2
    9925 Airway Road
    City State/Province/Country ZIP/PostalCode
    San Diego CALIFORNIA 92154
    Relationship: X Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    Last Name First Name Middle Name
    Halamuda Jerry
    Street Address 1 Street Address 2
    9925 Airway Road
    City State/Province/Country ZIP/PostalCode
    San Diego CALIFORNIA 92154
    Relationship:    Executive Officer X Director    Promoter

    Clarification of Response (if Necessary):


    4. Industry Group

       Agriculture
    Banking & Financial Services
       Commercial Banking
       Insurance
       Investing
       Investment Banking
       Pooled Investment Fund
    Is the issuer registered as
    an investment company under
    the Investment Company
    Act of 1940?
       Yes    No
       Other Banking & Financial Services
       Business Services
    Energy
       Coal Mining
       Electric Utilities
       Energy Conservation
       Environmental Services
       Oil & Gas
       Other Energy
    Health Care
       Biotechnology
       Health Insurance
       Hospitals & Physicians
       Pharmaceuticals
       Other Health Care
    X Manufacturing
    Real Estate
       Commercial
       Construction
       REITS & Finance
       Residential
       Other Real Estate
      
    Retailing
      
    Restaurants
    Technology
       Computers
       Telecommunications
       Other Technology
    Travel
       Airlines & Airports
       Lodging & Conventions
       Tourism & Travel Services
       Other Travel
      
    Other

    5. Issuer Size

    Revenue Range OR Aggregate Net Asset Value Range
       No Revenues    No Aggregate Net Asset Value
       $1 - $1,000,000    $1 - $5,000,000
       $1,000,001 - $5,000,000    $5,000,001 - $25,000,000
       $5,000,001 - $25,000,000    $25,000,001 - $50,000,000
       $25,000,001 - $100,000,000    $50,000,001 - $100,000,000
       Over $100,000,000    Over $100,000,000
    X Decline to Disclose    Decline to Disclose
       Not Applicable    Not Applicable

    6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

       Rule 504(b)(1) (not (i), (ii) or (iii))
       Rule 504 (b)(1)(i)
       Rule 504 (b)(1)(ii)
       Rule 504 (b)(1)(iii)
    X Rule 506(b)
       Rule 506(c)
       Securities Act Section 4(a)(5)
       Investment Company Act Section 3(c)
       Section 3(c)(1)    Section 3(c)(9)  
       Section 3(c)(2)    Section 3(c)(10)
       Section 3(c)(3)    Section 3(c)(11)
       Section 3(c)(4)    Section 3(c)(12)
       Section 3(c)(5)    Section 3(c)(13)
       Section 3(c)(6)    Section 3(c)(14)
       Section 3(c)(7)

    7. Type of Filing

    X New Notice Date of First Sale 2024-03-26    First Sale Yet to Occur
       Amendment

    8. Duration of Offering

    Does the Issuer intend this offering to last more than one year?
       Yes X No

    9. Type(s) of Securities Offered (select all that apply)

       Equity    Pooled Investment Fund Interests
    X Debt    Tenant-in-Common Securities
    X Option, Warrant or Other Right to Acquire Another Security    Mineral Property Securities
       Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security    Other (describe)

    10. Business Combination Transaction

    Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
       Yes X No

    Clarification of Response (if Necessary):

    11. Minimum Investment

    Minimum investment accepted from any outside investor $50,000 USD

    12. Sales Compensation

    Recipient
    Recipient CRD Number    None
    MOODY CAPITAL SOLUTIONS, INC. 15989
    (Associated) Broker or Dealer X None
    (Associated) Broker or Dealer CRD Number X None
    None None
    Street Address 1 Street Address 2
    2458 DUNKERRIN LANE
    City State/Province/Country ZIP/Postal Code
    ATLANTA GEORGIA 30360
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
       Foreign/non-US
    MASSACHUSETTS
    NEW YORK

    Recipient
    Recipient CRD Number    None
    BOUSTEAD SECURITIES, LLC 141391
    (Associated) Broker or Dealer X None
    (Associated) Broker or Dealer CRD Number X None
    None None
    Street Address 1 Street Address 2
    6 VENTURE SUITE 395
    City State/Province/Country ZIP/Postal Code
    IRVINE CALIFORNIA 92618
    State(s) of Solicitation (select all that apply)
    Check “All States” or check individual States
       All States
       Foreign/non-US
    MASSACHUSETTS
    NEW YORK

    13. Offering and Sales Amounts

    Total Offering Amount $1,226,000 USD
    or    Indefinite
    Total Amount Sold $490,400 USD
    Total Remaining to be Sold $735,600 USD
    or    Indefinite

    Clarification of Response (if Necessary):

    14. Investors

      
    Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
    0
    Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
    2

    15. Sales Commissions & Finder's Fees Expenses

    Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

    Sales Commissions $88,272 USD
    X Estimate
    Finders' Fees $0 USD
       Estimate

    Clarification of Response (if Necessary):

    Estimated commissions assuming maximum offering amount is sold.

    16. Use of Proceeds

    Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

    $0 USD
       Estimate

    Clarification of Response (if Necessary):

    Signature and Submission

    Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

    Terms of Submission

    In submitting this notice, each issuer named above is:
    • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
    • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
    • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

    Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

    For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

    Issuer Signature Name of Signer Title Date
    Hempacco Co., Inc. /s/ Sandro Piancone Sandro Piancone President and CEO 2024-04-02

    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

    * This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


    Get the next $HPCO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hempacco Receives Notification of Deficiency from Nasdaq

    San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

    5/31/24 4:12:00 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

    NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

    5/6/24 9:30:00 AM ET
    $BNZI
    $HPCO
    $LRHC
    Computer Software: Prepackaged Software
    Technology
    Medicinal Chemicals and Botanical Products
    Health Care

    New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

    NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

    3/28/24 9:15:00 AM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Titus Stuart W

    4 - Hempacco Co., Inc. (0001892480) (Issuer)

    5/31/23 4:24:54 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

    3 - Hempacco Co., Inc. (0001892480) (Issuer)

    5/31/23 4:24:18 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    $HPCO
    SEC Filings

    View All

    Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    8-K - Hempacco Co., Inc. (0001892480) (Filer)

    10/10/24 5:00:29 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Hempacco Co., Inc. (0001892480) (Filer)

    9/9/24 12:45:38 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Hempacco Co., Inc. (0001892480) (Filer)

    8/23/24 4:51:27 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care

    $HPCO
    Leadership Updates

    Live Leadership Updates

    View All

    Hempacco Announces Opening of European Office as Part of International Expansion Strategy

    Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

    4/4/23 9:00:00 AM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care